Literature DB >> 7797074

Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.

R L Beijersbergen1, L Carlée, R M Kerkhoven, R Bernards.   

Abstract

The orderly progression through the cell cycle is mediated by the sequential activation of several cyclin/cyclin-dependent kinase (cdk) complexes. These kinases phosphorylate a number of cellular substrates, among which is the product of the retinoblastoma gene, pRb. Phosphorylation of pRb in late G1 causes the release of the transcription factor E2F from pRb, resulting in the transcriptional activation of E2F-responsive genes. We show here that phosphorylation of the pRb-related p107 is also cell cycle regulated. p107 is first phosphorylated at 8 hr following serum stimulation of quiescent fibroblasts, which coincides with an increase in cyclin D1 protein levels. Consistent with this, we show that a cyclin D1/cdk4 complex, but not a cyclin E/cdk2 complex, can phosphorylate p107 in vivo. Furthermore, phosphorylation of p107 can be abolished by the overexpression of a dominant-negative form of cdk4. Phosphorylation of p107 results in the loss of the ability to associate with E2F-4, a transcription factor with growth-promoting and oncogenic activity. A p107-induced cell cycle block can be released by cyclin D1/cdk4 but not by cyclin E/cdk2. These data indicate that the activity of p107 is regulated by phosphorylation through D-type cyclins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7797074     DOI: 10.1101/gad.9.11.1340

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  88 in total

1.  Serum-induced expression of the cdc25A gene by relief of E2F-mediated repression.

Authors:  X Chen; R Prywes
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  E1A blocks hyperphosphorylation of p130 and p107 without affecting the phosphorylation status of the retinoblastoma protein.

Authors:  M Parreño; J Garriga; A Limón; X Mayol; G R Beck; E Moran; X Graña
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 3.  Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.

Authors:  R J Michalides
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

4.  Differential control of transcription by DNA-bound cyclins.

Authors:  T Y Kim; W G Kaelin
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

Review 5.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

6.  Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins.

Authors:  J Hermanns; A Schulze; P Jansen-Db1urr; J A Kleinschmidt; R Schmidt; H zur Hausen
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

7.  Induction of S-phase entry by E2F transcription factors depends on their nuclear localization.

Authors:  H Müller; M C Moroni; E Vigo; B O Petersen; J Bartek; K Helin
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

8.  Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells.

Authors:  Tiziana Parisi; Andreas R Beck; Nathalie Rougier; Tom McNeil; Linda Lucian; Zena Werb; Bruno Amati
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

9.  Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130.

Authors:  Jan-Hermen Dannenberg; Leontine Schuijff; Marleen Dekker; Martin van der Valk; Hein te Riele
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

10.  Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor.

Authors:  E Castaño; Y Kleyner; B D Dynlacht
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.